Dr. Holemon serves as Entrepreneur-in-Residence at the St. Louis BioGenerator. She has extensive scientific, strategy and business development experience. Before joining BioGenerator, she was Head of Life Science Reagents and Kits for MilliporeSigma. Prior to the acquisition of Sigma-Aldrich by Merck, Dr. Holemon worked at Sigma-Aldrich for over ten years in varied roles including Principal Scientist, R&D Manager, Manager of Strategy and Corporate Development and Director of Business Development for Applied Markets. Earlier in her career she served in senior scientific and R&D roles with Incyte Genomics, Mattson Jack Group, ProteoPlex, EMD Biosciences and Orion Genomics. She holds a Ph.D. in Molecular Biology and an M.B.A. from Washington University.
